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Abstract
Osteoarthritis (OA)-associated pain is a leading cause of disability. Central sensitization (CS), as a result of OA, is recognized as an
important facet of human patients’ chronic pain and has been measured in people using quantitative sensory testing (QST) testing.
The spontaneous canine OAmodel has been suggested as a good translational model, but CS has not been explored in this model.
In this study, QSTwas performed on dogs with andwithout spontaneous hip or stifle OA to determine whether OA is associated with
CS in this model. Mechanical (von Frey and blunt pressure) and thermal (hot and cold) sensory thresholds obtained in dogs with
chronic OA-associated pain (n 5 31) were compared with those of normal dogs (n 5 23). Dogs were phenotyped and joint-pain
scored, and testing was performed at the OA-affected joint, cranial tibial muscle, and dorsal metatarsal region. QST summary data
were evaluated using mixed-effect models to understand the influence of OA status and covariates, and dogs with OA and control
dogs were compared. The presence of OA was strongly associated with hyperalgesia across all QST modalities at the index joint,
cranial tibial muscle, and metatarsal site. Mechanical QST scores were significantly moderately negatively correlated with total joint-
pain scores. The spontaneous canine OA model is associated with somatosensory sensitivity, likely indicative of CS. These data
further validate the canine spontaneous OA model as an appropriate model of the human OA pain condition.
Keywords: Animal model, Osteoarthritis, Spontaneous osteoarthritis model, Quantitative sensory testing
1. Introduction
Osteoarthritis (OA) is the most common form of arthritis and is
considered a leading cause of disability in humans (27million U.S.
adults and 8.5 million U.K. adults).33 Osteoarthritis is a major
contributor to the economic impact of chronic pain, and a 2011
report from the Institute of Medicine highlighted that the
economic cost of persistent pain (approximately $600 billion
annually) was more than the economic cost of cardiovascular
disease ($300 billion) and cancer ($250 billion) combined.11,18
Additionally, numerous reviews5,35,40,48 have highlighted a crip-
pling lack of translation of basic research into new approved
therapeutics for treatment of persistent pain in humans. The use
of spontaneous painful disease in companion animals was
highlighted as one of the changes that could be made to help
improve translation of basic science to new therapeutics.38
In dogs, spontaneously occurring OA is a condition affecting
a large percentage of the population, with an estimated 20% to
30% of the dog population having OA and associated clinical
signs.25 The pathophysiology of canine OA of the hip is considered
to be very similar to humanOA,13making dogs suitable candidates
to be used as spontaneous disease models.24 Additionally, the
canine stifle joint is considered to be among the most similar to the
human knee joint.14 The pain associated with canine OA can be
difficult to control,31 and indeed, OA-associated pain is one of the
most common reasons for euthanasia in dogs.32,36 One of the
reasons for the difficulty in controlling pain in dogs may be the
presence of central plasticity, as in humanswith OA.2,4,15 Although
many aspects of this spontaneous canine OA model have been
well developed including objective measures of limb use,19
objective measures of activity,50 validated owner-completed
clinical metrology instruments,8,49 and measures of sleep distur-
bance,28 measures of enhanced processing of nociceptive stimuli
resulting from peripheral and central mechanisms associated
with spontaneous canine OA have received little attention. Early
work has evaluated the repeatability of quantitative sensory
testing measures,6,51 and 2 small studies have suggested the
presence of enhanced pain processing in association with
cruciate ligament rupture10 and hind limb OA.51 Additionally,
one study concluded that unilateral total hip replacement in
client-owned dogs with bilateral hip OA resulted in decreased
central sensitization (CS), as measured using von Frey
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thresholds 12 months after surgery47; however, controls were
not evaluated. To optimally exploit this spontaneous canine
model of OA for future comparative and translational research,
more needs to be understood about nociceptive pain sensitivity
and central plasticity in association with OA.
The primary aim of this study was to evaluate mechanical and
thermal quantitative sensory testing (QST) in dogs with chronic OA-
associated pain and in matched control dogs. We hypothesized
that QST would be able to detect differences in somatosensory
processing between normal dogs and dogswith naturally occurring
OA, paralleling the findings in humans with OA.
2. Material and methods
The study protocol was approved by the Institutional Animal Care
and Use Committee of North Carolina State University (protocol
11-073-O).
2.1. Animals
Client-owned dogs of both groups (OA affected and controls) were
recruited over a 14-month period. Recruitment was conducted
with the assistance of the Clinical Studies Core at the NC State
Comparative Medicine Institute (https://cvm.ncsu.edu/research/
centers/cmi/) using email advertisements within the veterinary
college and NC State University community, email and paper flyer
advertisements at local veterinary practices in Raleigh, and through
local newspaper advertisements. All owners were shown pictures
and videos of the proposed procedures and gave verbal and
written informed consent before entering their pet into the study.
2.2. Screening
All dogs were required to be older than 2 years and weigh$15 kg.
Prestudy in-hospital screening consisted of physical examination
including body condition score (BCS),30 orthopedic and neurologic
examination, complete blood count, serum biochemical analysis,
and voided urinalysis. Orthopedic examination (performed by
a single individual [D.K.] trained by B.D.X.L.) evaluated gait
(lameness, stiffness, and posture), joint manipulation (range of
motion, pain, crepitus, effusion, and thickening), and the degree of
muscle atrophy. The total number of painful appendicular joints and
spinal segments was recorded. There is no validated subjective
pain assessment scale, and in this study, pain responses detected
during joint and spinal segment palpation were scored on a 5-point
scale, with 0 5 no pain and 4 5 severe pain (Table 1), similar to
other studies.20,46 Total pain score was recorded as a sum of
scores across all joints and spinal segments. In dogs in which OA
was present bilaterally in hips and/or stifles or in both hip and stifle
joints, the index joint was determined based on the highest pain
score, confirmed by a second opinion evaluation (B.D.X.L.).
Radiographic examination was performed under sedation to
confirm the presence of OA. Two orthogonal views were taken of
all clinically painful appendicular joints and only dogs with
subjectively moderate or severe radiographic OA were included.
Dogs were sedated using a combination of dexmedetomidine
(Zoetis, Florham Park, NJ) (0.003 mg/kg intravenously) and
hydromorphone (West-Ward Pharmaceuticals, Cherry Hill, NJ)
(0.05 mg/kg intravenously) and reversal with atipamezole (Zoetis)
(0.1 mg/kg intramuscularly). Dogs were excluded if there was
evidence of clinically detectable neurologic disease or other
systemic disease that could be associated with pain.
Eligible dogs with OA were required to have a 6-month history
of impaired mobility as reported by the owner. Mobility
impairment was assessed through a review of owner-
completed validated clinical metrology instruments: the Liverpool
Osteoarthritis in Dogs (LOAD)21,49 and Canine Brief Pain In-
ventory (CBPI).8 The LOAD21,49 is a 13-item instrument with all
items reported on a 5-point Likert-type scale. Each item is scored
between 0 and 4, and the item scores are summed to give an
overall instrument score. The CBPI8,9 is a 2-part instrument: the
pain severity score is the arithmetic mean of 4 items scored on an
11-point (0-10) numerical scale, and the pain interference score is
the mean of 6 items scored similarly. One question asks about
quality of life, scored 1 to 5 (poor to very good). Dogs with OA
were required to not be currently receiving any anti-inflammatory
medications or other analgesics (eg, amantadine and gabapen-
tin), and also not be on nutritional supplements (eg, fish oil and
“joint supplements”), or have been on them for 6 weeks or more
before the time to be included in the study.
Control dogs were recruited with the aim of representing the
typical phenotype of the average dog with clinically significant OA
in terms of age, breed, and weight, characteristics that are well
known from other studies31,49,50 and clinical orthopedics.
Additional inclusion criteria were no evidence of abnormalities
on orthopedic examination (no pain, no decreased muscle mass,
no neurological deficits, and no joint instability or other pathology),
no history of impairment recognized by owner, and not receiving
anti-inflammatory medications, other analgesics, or nutritional
supplements. Canine Brief Pain Inventory was also used to
assess normality of mobility, where mean CBPI scores of less
than 0.75 for pain intensity and pain interference and quality of life
scores of 4 (very good) or greater7 were required.
2.3. Sensory testing design
Quantitative sensory testingwas performed in a dedicated space,
theGait Laboratory (a 153 5m isolated roomwith 2 doors and no
windows) at the NCSU College of Veterinary Medicine. Quanti-
tative sensory testing data were collected on each dog 7 days
after screening.
2.3.1. Devices
2.3.1.1. Electronic von Frey
The electronic von Frey (EVF) device (IITC model Almemo 2450;
IITC Life Sciences Inc, Woodland Hills, CA) consisted of a 1000-g
internal load cell connected to a modified 0.5-mm diameter
Table 1
Pain scoring system used during orthopedic evaluation of
pain severity of appendicular and axial segments.
Pain score Description of responses
0 Does not notice manipulation (no pain)
1 Orients to site on manipulation, does not resist or
mild resistance (mild)
2 Orients to site, slight objection to manipulation
(moderate)
3 Withdraws from manipulation, may vocalize, may
turn to guard area (significant)
4 Tries to escape from manipulation, or prevent
manipulation, may bite or show aggression on
manipulation (severe pain)
For this scoring, the manus and pes were considered a “single-joint area.” Other joints scored were the carpi,
elbows, shoulders, tarsi, stifles, and coxofemoral joints. The axial skeletal regions scored were the cervical,
thoracic, lumbar, and lumbosacral regions. The addition of scores for each individual joint or axial skeletal
region comprised the total pain score for that individual.
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pipette tip, as described previously.6 The amount of force applied
to a test site was measured and displayed with a resolution of 0.1
g and maximum of 1000 g.
2.3.1.2. Pressure algometer
The blunt-probed pressure algometer (PA) (SMALGO algometer;
Bioseb, Vitrolles, France) was equipped with a flat, 3-mm
diameter tip attached to a recording unit. Internal software of
the device recorded themaximum force applied at the test site up
to a maximum of 2500 g.
2.3.1.3. Thermal probe
The thermal device (NTE-2A; Physitemp Instruments, Clifton, NJ)
was composed of a hand-held probe equippedwith a flat, 13-mm
diameter tip on a 5-foot lead connected to a digital temperature
control unit and recirculating pump with combined water
reservoir. The temperature range of the probe tip could be
altered to have a temperature between 0˚C and 50˚C, maintained
to within 0.1˚C. This device was used to deliver a hot thermal
stimulus (49˚C) and a cold thermal stimulus (0˚C).
2.4. Testing sites
Three test sites on each hind limb were located and identified
(Figure 1), and consisted of the index joint (hip or stifle), the cranial
tibial muscle, and the metatarsal area. The locations of testing at
the 3 sites were as follows: (1) index joint: either the hip
joint—testing site located 2 cm craniodorsally from greater
trochanter or the stifle joint, testing site located 2 cm laterally
from apex of patella, (2) tibial muscle—center of cranial tibial
muscle at dorsolateral position, and (3) metatarsal—dorsal
surface of the metatarsus between metatarsal bones III and IV,
as previously described.37
The endpoint for both thermal and mechanical stimuli was
defined as a behavioral response indicative of a conscious
perception of the stimulus: movement of the limb away from the
tip or probe with conscious perception, turning the head to look
directly at the site, vocalization, or other consistent, clearly
recognizable body movement indicating perception of the
stimulus (see supplementary data: Video 1, available online at
http://links.lww.com/PAIN/A240). Simple reflex movements
(such as twitching) were not considered an endpoint. Each
dog was assigned a feasibility score as previously described,6
which represents the ease with which the data could be
collected for each device and each site (0-5 scale with
0 indicating no problem in collecting the data and 5 indicating
the data were impossible to collect).
2.5. Protocol
Gait Laboratory room temperature was maintained between
21.7˚C and 22.2˚C. All dogs were introduced to the Gait
Laboratory for acclimatization and were allowed to freely explore
the environment for 20 minutes before testing. Two people were
used for all QST procedures and data collection, but all sensory
thresholdmeasurements were collected by the sameoperator (D.
K.). Food rewards were offered to dogs occasionally and fresh
water was available in the roomad libitum. After acclimating, dogs
were placed in lateral recumbency on a standard cushioned mat
(0.5 cm thick, 2.0 m long, and 1.0 m wide). For measuring the
thresholds on the left pelvic limb, dogs were placed in the right
lateral recumbency, and vice versa. The devices were used in
a set order at each site: EVF, PA, hot thermal, and then cold
thermal. The order of testing sites for cases was randomized at
the start of the study, using blinded drawing of numbers from
a hat.
Mechanical stimuli (EVF and PA) were applied as ramped
stimuli, with steadily increasing force applied until the behavioral
response was elicited or the maximum value was reached (EVF,
1000 g; PA, 2500 g). The left hand of the operator (D.K.) was
placed behind the paw for support during metatarsal-site testing
and on the medial side of tibia during muscle-site testing.
Thresholds were measured in grams.
The hot and cold stimuli were applied as fixed intensity stimuli.
Hair on the 3 sites was clipped creating a 15-mm diameter area
before any testing. Hot and cold stimuli represented probe
settings of 49˚C (cutoff time, 20 seconds) and 0˚C (cutoff time, 60
seconds), respectively. The latency to respond was measured in
seconds for both thermal stimuli using a digital stopwatch (Seiko
W073; Seiko, Tokyo, Japan) with the precision of one-hundredth
of a second.
Data were collected on both hind limbs, with 5 trials per site on
each limb and a 60-second intertrial interval between the
applications of stimuli.
2.6. Statistical analysis
Group comparisons of demographics were performed using
Mann–Whitney tests. The primary measures of interest were the
QST measures, and sample size calculations were based on
previous von Frey threshold data. In pilot work in our laboratory,
the expected mean difference between normal dogs and dogs
with OA was found to be 158 g with a combined SD of 127 g,
indicating that for a power of 90%, at an alpha of 0.05, 15 dogs
would be needed per group.
Figure 1. The locations of testing at the 3 sites were as follows: (1) index joint:
either the hip joint—testing site located 2 cm craniodorsally from greater
trochanter or the stifle joint, testing site located 2 cm laterally from apex of
patella, (2) tibial muscle—center of cranial tibial muscle at dorsolateral position,
and (3) metatarsal—dorsal surface of the metatarsus, between metatarsal
bones III and IV.
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Exploratory analyses tested for a linear effect across trials in
a repeated-measures mixed-effects model, and this analysis did
not reveal that a strong linear effect across trials was present. The
QST data were evaluated using repeated-measures mixed-
effects models to understand the influence of covariates.
Separate mixed-effect repeated-measures models were made
for each QST modality (EVF, PA, hot thermal probe, and cold
thermal probe) at each of the 3 testing sites (index joint, muscle,
and metatarsal) such that there were twelve models in total. In
each model, the following covariates were included: OA status,
sex, side (left or right), body condition score, and the feasibility of
the QST measurement. The optimal covariance structure for the
within-subject measures across trial and side was tested using
likelihood ratio tests, starting with the most complicated co-
variance structure first and then sequentially comparing simpler
designs. The covariance designs that were compared for the
within-subject measures across trial were random slopes with
unstructured and Toeplitz covariance structure. The within-
subject random intercept for side was compared with a model
with just a random subject-specific intercept. At minimum, each
model included a random subject-specific intercept.
The association between OA, sex, side, body condition score,
and the feasibility of the QST measurement and the QST
threshold was assessed using Wald tests. P values were not
adjusted for multiple comparisons.
Following the above analysis, direct group comparisons for the
average of each QST modality across trial and side were made
using nonparametric analyses (Wilcoxon rank sums).
In exploratory analysis, correlations were performed be-
tween mechanical QST thresholds and clinical parameters
(total pain score, number of painful joints, LOAD, and CBPI)
using Spearman rank correlation coefficient (Spearman rho),
denoted “r.” Correlations were interpreted as very weak (0-
0.19), weak (0.2-0.39), moderate (0.4-0.59), strong (0.6-0.79),
or very strong (0.8-1.0).16
3. Results
Fifty-four dogs, 31 with OA, were recruited for the study. The
demographics are shown in Table 2. Of the enrolled dogs with
OA, 20 dogs had the hip joint identified as the index joint and 11
dogs had the stifle joint identified as the index joint. Most of the
examined dogs had concurrent stifle and hipOA.Only 2 dogs had
unilateral OA with only one joint affected.
3.1. Comparison of clinical parameters of dogs
When comparing all dogs from both groups (OA, controls), the
age of the dogs with OA was significantly higher (P 5 0.007),
although the difference was only 2 years, with the control dogs
being younger. Bodyweight was not significantly different (P 5
0.523) when comparing all dogs from both groups (OA, controls).
3.2. Quantitative sensory testing data
3.2.1. Mixed-effects models to determine which factors
affect thresholds
Presence of OA was a strong predictor of the QST area under the
curve (AUC) summary measure in all of the models (see Tables
3–6) except for the PA at themetatarsal site (Table 3) and the EVF
at the index joint site and the tibial muscle site (Table 4). No other
factors consistently or significantly affected QST measures across
all modalities. We found that feasibility may be an important
predictor for the EVF and hot thermal thresholds at the index joints
(Table 4and5, respectively).We also found thatBCSseemed tobe
strongly associatedwith the hot thermalmeasures at themetatarsal
and tibialmuscle sites (Table5middle and right columns). Age, sex,
and side did not seem to be strongly associatedwith any of theQST
AUC measures at any of the 3 sites (index joint, tibial muscle, and
metatarsal) for any QST modality.
3.2.2. Direct group comparisons
Following the aforementioned analysis, QST values were
averaged over the left and right limbs, across all trials, for each
dog. QST results for all dogs with OA and normal dogs are
detailed in Table 7. P values were not adjusted for multiple
comparisons; however, if a correction to the critical P value of
0.05/3 (50.016) is used for eachQSTmodality (3 different sites), it
can be seen (Table 7) that all comparisons are significant at the
0.016 critical level.
Table 2
Summary of characteristics of both groups (osteoarthritis
[OA] and controls).
OA (N5 31) Control (N5 23) All (N5 54)
Sex
Male castrated 15 11 26
Female spayed 16 12 28
Age (y)
Median 8.00 7.00 7.00
Range (min-max) 4-17 3-11 3-17
Mean 8.71 6.74 7.67
SD 2.77 1.91 2.71
SEM 0.50 0.40 0.37
Bodyweight (kg)
Median 29.00 28.30 28.90
Range (min-max) 18-50.2 21-42 18-50.2
Mean 31.05 29.76 30.50
SD 7.69 7.03 7.37
SEM 1.38 1.47 1.00
Total pain score
Median 7.00 0 4.50
Range (min-max) 3-23 0 0-23
Mean 9 0 5.17
SD 4.89 0 5.81
SEM 0.88 0 0.79
Total number of painful areas
Median 4.00 0 2.00
Range (min-max) 2-12 0 0-12
Mean 4.84 0 2.78
SD 2.63 0 3.12
SEM 0.47 0 0.43
Breed
Mixed breed 12 8 20
Labrador retriever 6 4 10




Boxer 1 0 1
Catahoula leopard 1 0 1
English setter 1 0 1
Australian cattle dog 1 1 2
Brittany spaniel 1 0 1
Otterhound 1 1 2
Rottweiler 1 0 1
Welsh springer spaniel 1 0 1
Australian shepherd dog 0 1 1
German shorthaired pointer 0 1 1
1328 D. Knazovicky et al.·157 (2016) 1325–1332 PAIN®
Copyright  2016 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
3.2.2.1. Electronic von Frey
Dogs with OA showed significantly lower thresholds at the index
joint andmetatarsal sites (P5 0.006 and P5 0.014, respectively)
(Table 7).
3.2.2.2. Pressure algometer
Dogs with OA showed significantly lower thresholds at the index
joint, tibial muscle, and metatarsal sites (P, 0.0001, P5 0.001,
and P 5 0.005, respectively) (Table 7).
3.2.2.3. Thermal probe—heat
Dogs with OA showed significantly lower thresholds at the index
joint, tibial muscle, and metatarsal sites (P , 0.0001, P 5
,0.001, and P , 0.0001, respectively) (Table 7).
3.2.2.4. Thermal probe—cold
Dogs with OA showed significantly lower thresholds at the index
joint, tibial muscle, and metatarsal sites (P, 0.0001, P5 0.001,
and P 5 ,0.001, respectively) (Table 7).
3.3. Correlations
There were significant moderate negative correlations between
mechanical thresholds at the metatarsal site and total pain
scores (EVF [r 5 20.49, P 5 0.006] and PA [r 5 20.37, P 5
0.04]). There were significant weak or moderate negative
correlations between the total number of painful joints and
mechanical thresholds at the index joint site (EVF [r 5 20.38,
weak correlation, P 5 0.04] and PA [r 5 20.44, moderate
correlation, P 5 0.02]) and also the metatarsal site (EVF [r 5
20.44, moderate correlation, P 5 0.02]).
Total pain score and LOAD and CBPI scores were significantly
positively correlated (LOAD [r 5 0.42, moderate correlation, P 5
0.02] and CBPI [r 5 0.37, weak correlation, P 5 0.04]). The
number of painful joints was significantly and weakly positively
correlated with CBPI scores (r 5 0.39, P 5 0.03), but not with
LOAD scores (r 5 0.34, P 5 0.06). There were no significant
correlations between owner-completed clinical metrology instru-
ments (CMIs) and QST values for any modality.
4. Discussion
We found significantly lower mechanical and thermal thresholds
at index joints and at sites remote from the affected joints (tibial
muscle andmetatarsal) in dogswithOA as comparedwith control
dogs without OA. This increased sensitivity to mechanical and
thermal stimuli remote from the OA-affected joint could indicate
the presence of enhanced pain processing resulting from central
and, or, peripheral sensitization, with peripheral sensitization
driven by circulating proinflammatory or pain-promoting sub-
stances. Our results support the findings of facilitated nociceptive
transmission because of central plasticity in rodent models of
OA22,26 and humans with OA.2,23,45 However, it is not known
from this work whether the sensitization is driven by spinal cord
changes, or alterations in endogenous descending pathways as
have been described in humans,41 or, indeed, is driven by
peripheral mechanisms. The facilitated nociceptive transmission
could be a product of all 3 mechanisms. These data further
validate the canine spontaneous OA model as an appropriate
model of the humanOA pain condition. Previous work has shown
mechanical and thermal QST testing to be highly feasible and
repeatable in normal, client-owned dogs,6 and our present work
indicates that QST data can be collected easily in dogs with OA,
Table 3
Fixed-effects estimates for predicting the blunt pressure thresholds (pressure algometer) at the affected joint, the metatarsal
site, and the tibial muscle.
Effect Index joint Metatarsal Tibial muscle
Estimate 95% CI P Estimate 95% CI P Estimate 95% CI P
Intercept 2359.4 1407.4 1270.8
OA 2423.0 2681.8 to 2164.2 0.001 2193.7 2411.7 to 24.2 0.081 2374.0 2653.9 to 294.1 0.009
Age 28.3 253.5 to 36.9 0.718 226.5 263.8 to 10.8 0.163 220.7 269.6 to 28.2 0.405
Female 261.5 2273.4 to 150.3 0.568 262.9 2245.0 to 119.2 0.498 279.2 2308.3 to 149.9 0.496
Side 5 L 229.2 2106.4 to 48.1 0.452 2.3 260.7 to 65.3 0.942 65.7 213.7 to 145.2 0.103
BCS 261.2 2235.2 to 112.7 0.489 25.6 2122.0 to 173.1 0.734 70.5 2117.6 to 258.7 0.461
Feasibility 26.5 2107.1 to 160.2 0.697 45.3 251.7 to 142.4 0.359 11.6 2132.9 to 156.2 0.874
For the fixed-effects estimates, the reference value is the first trial, right side, and male gender. The intercept represents the expected average QST value for the first trial if the dog was a control male measured on the right side.
BCS, body condition score; CI, confidence interval; L, left; OA, osteoarthritis.
Table 4
Fixed-effects estimates for predicting the von Frey thresholds (electronic von Frey) at the affected joint, the metatarsal site, and
the tibial muscle.
Effect Index joint Metatarsal Tibial muscle
Estimate 95% CI P Estimate 95% CI P Estimate 95% CI P
Intercept 1114.3 532.5 471.8
OA 2118.0 2245.4 to 9.5 0.070 2141.6 2266.9 to 216.2 0.027 2144.6 2280.3 to 28.9 0.037
Age 7.6 214.7 to 29.9 0.503 20.6 222.0 to 20.7 0.952 22.9 226.6 to 20.9 0.813
Female 220.9 2124.5 to 82.6 0.692 219.8 2124.9 to 85.3 0.711 12.1 298.1 to 122.3 0.829
Side 5 L 219.4 264.8 to 26.0 0.396 27.5 27.5 to 62.6 0.121 222.9 262.3 to 16.6 0.250
BCS 273.9 2159.5 to 11.8 0.091 5.1 279.3 to 89.6 0.905 15.5 275.7 to 106.7 0.739
Feasibility 264.4 2125.4 to 23.5 0.038 6.5 249.2 to 62.1 0.819 3.1 261.8 to 68.0 0.925
For the fixed-effects estimates, the reference value is the first trial, right side, and male gender. The intercept represents the expected average QST value for the first trial if the dog was a control male measured on the right side.
BCS, body condition score; CI, confidence interval; L, left; OA, osteoarthritis.
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making this canine model of spontaneous OA useful for the
evaluation of somatosensory processing.
Lower thresholds at the affected joint of dogs with OA
compared with normal controls could be due to a combination
of peripheral and CS, but lower thresholds remote from the
affected joints are generally inferred to be due to CS. However, it
is plausible that this remote hyperalgesia may be partly driven by
generalized changes in the periphery, although this concept has
not received any discussion, even in recent reviews.3,12
QST is the most common method used to assess pain
sensitivity through application of a standardized stimulus to
a peripheral tissue and the recording of a subject’s response.1
We found that dogs with long-standing OA-associated pain
showed lower thresholds across all QST modalities (EVF, PA,
hot thermal, and cold thermal). Most studies in human subjects
assessing mechanical thresholds have reported lower thresh-
olds in patients with OA than in controls, regardless of whether
the devices were applied at the affected joint (eg, knee) or
remote sites, including thumb and shoulder34 or forearm.53 For
example, Imamura et al. reported significantly lower mechan-
ical thresholds in people with knee OA, than in controls, at 18
anatomical test sites including upper thigh and lower back.23 A
recent systematic review and meta-analysis concluded that
there was a large difference in pain pressure thresholds
between patients with knee OA and normal controls, with
patients with knee OA showing increased sensitivity at both the
local site (joint) and remote sites.17 Evaluating thermal thresh-
olds, one study reported that human patients with OA had
significantly higher median warm and cold detection thresholds
(hypoesthesia) than healthy participants at the knee, but not the
forearm.53 Recording of any threshold in nonverbal species is
dependent on the behavioral endpoints of reactions to the
stimulus. Whether these reactions represent thermal detection
thresholds or tolerance thresholds is currently unknown. We
assume that our recordings relate to “hot pain thresholds” as
measured in humans.29,52,53 We detected hot thermal hyper-
algesia at all 3 testing locations in dogs with OA compared with
controls. The recent systematic review of QST in patients with
knee OA compared with controls concluded that patients
with knee OA have significant hot pain sensitivity at remote
sites, but not at local sites (affected joints).17 However,
increased sensitivity to hot pain has been demonstrated in
human subjects with chronic musculoskeletal pain39,44 and in
patients with high-symptom OA.27 The dogs in this study
represented moderate-to-severe OA, suggesting similarity to
the findings in humans. Our finding of cold hypersensitivity also
supports the finding of previous work in another spontaneous
pain model in dogs, cruciate ligament rupture.10 In humans,
widespread cold hypersensitivity was detected in subjects with
chronic whiplash-associated pain,42 and although a recent
meta-analysis was not able to draw conclusions on cold pain
sensitivity in patients with knee OA because of insufficient data,
increased cold pain sensitivity has been demonstrated in
patients with high-symptom OA.27
Our statistical models indicated that the dominant factor
affecting QST values across all modalities was OA status. Overall,
this naturally occurring model of OA in dogs would seem to be
a valid model of OA-associated somatosensory sensitivity
indicative of CS. In this study, dogs were recruited to the control
group to be generally similar in age, bodyweight, and breed as the
OA population (which is well characterized in veterinary med-
icine). The control group was significantly younger, by 2 years;
however, the statistical models indicated little influence of age on
QST thresholds in our cohorts. Our recommendation is that future
Table 5
Fixed-effects estimates for predicting hot thermal latencies (hot thermal) at the affected joint, the metatarsal site, and the tibial
muscle.
Effect Index joint Metatarsal Tibial muscle
Estimate 95% CI P Estimate 95% CI P Estimate 95% CI P
Intercept 9.6 3.9 1.8
OA 26.8 29.0 to 24.6 ,0.001 26.5 29.1 to 23.8 ,0.001 27.1 29.7 to 24.4 ,0.001
Age 0.2 20.2 to 0.6 0.301 0.1 20.3 to 0.6 0.652 0.2 20.3 to 0.7 0.393
Female 20.3 22.1 to 1.6 0.767 0.6 21.6 to 2.8 0.610 20.8 23.0 to 1.4 0.473
Side 5 L 0.3 20.7 to 1.2 0.548 20.3 21.3 to 0.7 0.583 20.8 22.1 to 0.6 0.267
BCS 1.5 0.0 to 3.1 0.055 2.6 0.7 to 4.4 0.006 2.6 0.7 to 4.5 0.007
Feasibility 21.0 21.9 to 20.1 0.038 20.6 21.6 to 0.4 0.208 21.0 22.1 to 0.1 0.080
For the fixed-effects estimates, the reference value is the first trial, right side, and male gender. The intercept represents the expected average QST value for the first trial if the dog was a control male measured on the right side.
BCS, body condition score; CI, confidence interval; L, left; OA, osteoarthritis.
Table 6
Fixed-effects estimates for predicting cold thermal latencies (cold thermal) at the affected joint, themetatarsal site, and the tibial
muscle.
Effect Index joint Metatarsal Tibial muscle
Estimate 95% CI P Estimate 95% CI P Estimate 95% CI P
Intercept 53.0 25.7 46.0
OA 2.0 1.0 to 3.0 ,0.001 217.9 228.0 to 27.8 0.001 213.7 220.5 to 26.8 ,0.001
Age 212.4 217.9 to 26.9 ,0.001 0.5 21.3 to 2.3 0.591 20.3 21.6 to 0.9 0.581
Female 0.7 20.3 to 1.6 0.197 21.8 211.5 to 7.9 0.716 22.8 29.3 to 3.7 0.396
Side 5 L 24.0 29.3 to 1.3 0.140 3.3 0.1 to 6.5 0.043 20.9 25.2 to 3.3 0.664
BCS 2.4 20.3 to 5.1 0.076 3.2 26.1 to 12.4 0.500 2.4 23.9 to 8.8 0.453
Feasibility 20.7 25.9 to 4.4 0.773 22.7 28.0 to 2.6 0.316 21.0 24.2 to 2.3 0.554
For the fixed-effects estimates, the reference value is the first trial, right side, and male gender. The intercept represents the expected average QST value for the first trial if the dog was a control male measured on the right side.
BCS, body condition score; CI, confidence interval; L, left; OA, osteoarthritis.
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studies should recruit controls that are similar to the affected
population, and consider formal matching of controls for age,
bodyweight, and BCS. Increasing BCS (correlating to increasing
obesity) was associated with increased sensitivity to mechanical
stimuli in this study, and although the relationship between
obesity and QST has not been evaluated in humans, obesity is
a risk factor for increased OA pain in humans.43
Validated clinical metrology instruments for owners of dogs
(CBPI and LOAD)8,9,21,49 were used in this study to measure
owner evaluations of pain and mobility impairment and to ensure
inclusion of normal, healthy, control dogs. Furthermore, these
scores were found to positively correlate with total pain scores
(assessed during evaluation of joints). Although increasing pain
scores were negatively correlated with mechanical thresholds (as
are self-reported pain scores in humans with OA27), there was no
correlation between CBPI or LOAD values and QST values.
Although the CBPI and LOAD primarily assess aspects of mobility
and a dog’s ability to perform certain activities that may be
influenced by pain, these instruments are not measuring pain
directly, although the CBPI pain severity subscale does ask about
pain.
5. Conclusions
Our study indicates that dogs with long-standing OA and
associated pain show increased somatosensory sensitivity,
which is inferred to be, at least in part, due to central plasticity.
Our study further supports spontaneous OA and associated pain
in dogs as a valid model of human OA-associated pain,
increasing the potential for use of this model in the development
of therapies for human OA pain.
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